ClinicalTrials.Veeva

Menu
M

Medical Centre Asklepii OOD | Dupnitsa, Bulgaria

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Apixaban
PF-04965842
Guselkumab
BFB759

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) (EMBARQ-CSU2)

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urtic...

Active, not recruiting
Chronic Spontaneous Urticaria
Biological: Matching placebo
Biological: barzolvolimab

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Enrolling
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis...

Active, not recruiting
Ulcerative Colitis
Drug: Guselkumab
Drug: Placebo

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Celldex Therapeutics logo
Pfizer logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems